{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458284622
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = Fab
| source = o
| target = colorectal tumor antigen C242
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 150631-27-9
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Nacolomab tafenatox''' is a [[mouse]] [[monoclonal antibody]]<ref name="WHO">[http://apps.who.int/medicinedocs/documents/h5806e/h5806e.pdf WHO Drug Information]</ref> designed for the treatment of [[colorectal cancer]].{{Citation needed|date=October 2009}} The antibody itself, nacolomab, is fused with [[enterotoxin]] A from ''[[Staphylococcus aureus]]'' (which is reflected by 'tafenatox' in the drug's name).<ref name="WHO" />

[[File:Fab-superantigen-fusion protein.svg|thumb|left|Schematic image of nacolomab tafenatox.<br />
'''V<sub>H</sub>''', '''V<sub>L</sub>''': variable (antigen binding) domains of antibody fragment<br />
'''C<sub>H</sub>1''', '''C<sub>L</sub>''': constant domains of antibody fragment<br />
'''SAg''': enterotoxin A (acting as a [[superantigen]])]]

==See also==
* [[Naptumomab estafenatox]], a drug with a similar chemical structure and mechanism

==References==
{{reflist}}

{{Monoclonals for tumors}}

{{DEFAULTSORT:Nacolomab Tafenatox}}
[[Category:Monoclonal antibodies for tumors]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}